RESUMEN
BACKGROUND: In 2009, untargeted metabolomics led to the delineation of a new clinico-biological entity called cerebellar ataxia with elevated cerebrospinal free sialic acid, or CAFSA. In order to elucidate CAFSA, we applied sequentially targeted and untargeted omic approaches. METHODS AND RESULTS: First, we studied five of the six CAFSA patients initially described. Besides increased CSF free sialic acid concentrations, three patients presented with markedly decreased 5-methyltetrahydrofolate (5-MTHF) CSF concentrations. Exome sequencing identified a homozygous POLG mutation in two affected sisters, but failed to identify a causative gene in the three sporadic patients with high sialic acid but low 5-MTHF. Using targeted mass spectrometry, we confirmed that free sialic acid was increased in the CSF of a third known POLG-mutated patient. We then pursued pathophysiological analyses of CAFSA using mass spectrometry-based metabolomics on CSF from two sporadic CAFSA patients as well as 95 patients with an unexplained encephalopathy and 39 controls. This led to the identification of a common metabotype between the two initial CAFSA patients and three additional patients, including one patient with Kearns-Sayre syndrome. Metabolites of the CSF metabotype were positioned in a reconstruction of the human metabolic network, which highlighted the proximity of the metabotype with acetyl-CoA and carnitine, two key metabolites regulating mitochondrial energy homeostasis. CONCLUSION: Our genetic and metabolomics analyses suggest that CAFSA is a heterogeneous entity related to mitochondrial DNA alterations either through POLG mutations or a mechanism similar to what is observed in Kearns-Sayre syndrome.
Asunto(s)
Ataxia Cerebelosa/diagnóstico , Genómica/métodos , Metabolómica/métodos , Ácido N-Acetilneuramínico/líquido cefalorraquídeo , Tetrahidrofolatos/líquido cefalorraquídeo , Adulto , Estudios de Casos y Controles , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/genética , Ataxia Cerebelosa/metabolismo , Análisis Mutacional de ADN , ADN Polimerasa gamma/genética , ADN Mitocondrial/análisis , Femenino , Humanos , Masculino , Espectrometría de Masas , Hermanos , Tetrahidrofolatos/análisis , Secuenciación del Exoma/métodosRESUMEN
The rare autosomal recessive disorder pyridoxine 5'-phosphate oxidase (PNPO) deficiency is a recently described cause of neonatal and infantile seizures. Clinical evaluation, and biochemical and genetic testing, were performed on a neonate with intractable seizures who did not respond to anticonvulsant drugs and pyridoxine. Sequencing of the PNPO gene revealed a novel homozygous c.284G>A transition in exon 3, resulting in arginine to histidine substitution and reduced activity of the PNPO mutant to 18% relative to the wild type. This finding enabled molecular prenatal diagnosis in a subsequent pregnancy, accurate genetic counseling in the large inbred family, and population screening.
Asunto(s)
Encefalopatías Metabólicas Innatas/enzimología , Encefalopatías Metabólicas Innatas/metabolismo , Piridoxaminafosfato Oxidasa/deficiencia , Piridoxina/metabolismo , Sustitución de Aminoácidos , Animales , Encefalopatías Metabólicas Innatas/diagnóstico , Encefalopatías Metabólicas Innatas/genética , Células CHO , Codón sin Sentido , Consanguinidad , Cricetinae , Cricetulus , Análisis Mutacional de ADN , Exones , Femenino , Expresión Génica , Pruebas Genéticas , Humanos , Recién Nacido , Masculino , Mutagénesis Sitio-Dirigida , Linaje , Mutación Puntual , Diagnóstico Prenatal , Piridoxaminafosfato Oxidasa/genética , Convulsiones/diagnóstico , Convulsiones/enzimología , Convulsiones/genética , Convulsiones/metabolismoRESUMEN
Tyrosine hydroxylase (TH) deficiency (OMIM 191290) is one cause of early-onset dopa-responsive dystonia. We describe seven cases from five unrelated families with dopa-responsive dystonia and low homovanillic acid in cerebrospinal fluid who were suspected to suffer from TH deficiency. Analysis of part of the TH promotor showed five homozygous and two heterozygous mutations in the highly conserved cyclic adenosine monophosphate response element. Our data suggest that, if no mutations are found in the coding regions of the gene in patients strongly suspected of TH deficiency, the search for pathogenic mutations should be extended to regulatory promotor elements.